A detailed history of Advance Capital Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Advance Capital Management, Inc. holds 9,952 shares of PFE stock, worth $257,060. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,952
Previous 10,187 2.31%
Holding current value
$257,060
Previous $285,000 1.05%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$27.7 - $31.39 $6,509 - $7,376
-235 Reduced 2.31%
9,952 $288,000
Q2 2024

Jul 08, 2024

SELL
$25.26 - $29.6 $2,652 - $3,108
-105 Reduced 1.02%
10,187 $285,000
Q1 2024

Apr 04, 2024

BUY
$25.89 - $29.73 $2,977 - $3,418
115 Added 1.13%
10,292 $285,000
Q4 2023

Jan 10, 2024

BUY
$26.13 - $33.94 $10,216 - $13,270
391 Added 4.0%
10,177 $292,000
Q3 2023

Oct 13, 2023

BUY
$32.09 - $37.51 $1,251 - $1,462
39 Added 0.4%
9,786 $324,000
Q2 2023

Jul 03, 2023

SELL
$36.12 - $41.79 $51,579 - $59,676
-1,428 Reduced 12.78%
9,747 $357,000
Q1 2023

Apr 04, 2023

SELL
$39.39 - $51.28 $1,851 - $2,410
-47 Reduced 0.42%
11,175 $455,000
Q4 2022

Feb 08, 2023

SELL
$41.75 - $54.5 $5,302 - $6,921
-127 Reduced 1.12%
11,222 $575,000
Q3 2022

Oct 28, 2022

BUY
$43.76 - $53.42 $4,551 - $5,555
104 Added 0.92%
11,349 $497,000
Q2 2022

Aug 08, 2022

BUY
$46.53 - $55.17 $17,867 - $21,185
384 Added 3.54%
11,245 $590,000
Q1 2022

May 03, 2022

BUY
$45.75 - $56.69 $15,326 - $18,991
335 Added 3.18%
10,861 $562,000
Q4 2021

Jan 14, 2022

BUY
$41.32 - $61.25 $434,934 - $644,717
10,526 New
10,526 $621,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Advance Capital Management, Inc. Portfolio

Follow Advance Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advance Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advance Capital Management, Inc. with notifications on news.